Werewolf Therapeutics Inc (HOWL) Annual Balance Sheets

Annual · GAAP · USD millions
Access HOWL quarterly Balance Sheets →
Examining balance sheet movements between Werewolf Therapeutics Inc and Dec 31 2021 reveals how Dec 31 2025 adjusts its asset composition and liability profile.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent57.05
Cash & Short-term Investments57.00
Other Receivables, Net, Current0.00
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.54
Total Current Assets58.59
Equipment/Property/Plant Net4.69
Other Assets, Noncurrent6.12
Restricted Cash Noncurrent0.90
Operating Lease Right Of Use Asset5.22
Total Assets69.40
Liabilities
Accounts Payable, Current AC0.75
Accrued Liabilities, Current AC5.41
Notes Payable, Current NO28.24
Other Liabilities, Current1.75
Total Current Liabilities36.15
Long-term debt0.00
Total Long-term Debt0.00
Derivative Liability, Noncurrent DE0.76
Other liabilities, Noncurrent7.68
Operating Lease Liability Current1.75
Operating Lease Liability Noncurrent7.68
Total Liabilities44.59
Stockholders' Equity
Common Stock Value48.60
Additional Paid In Capital Common Stock500.21
Retained Earnings / Accumulated Deficit-475.41
Other Equity-48.59
Common Stockholder's Equity24.81
Total Stockholder's Equity24.81
Liabilities & Stockholder's Equity69.40
4 historic quarters locked

Sign in to unlock the full Werewolf Therapeutics Inc balance sheet history.

About Werewolf Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001785530-26-000006

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.